{
    "Trade/Device Name(s)": [
        "HemosIL LA Positive Control",
        "HemosIL LA Negative Control"
    ],
    "Submitter Information": "Instrumentation Laboratory Co.",
    "510(k) Number": "K113211",
    "Predicate Device Reference 510(k) Number(s)": [
        "K110033"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GGN",
        "GGC",
        "GIZ"
    ],
    "Summary Letter Date": "October 27, 2011",
    "Summary Letter Received Date": "October 31, 2011",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR864.5425"
    ],
    "Regulation Name(s)": [
        "Multipurpose system for in vitro coagulation studies"
    ],
    "Analyte Class(es)": [
        "coagulation",
        "hematology"
    ],
    "Analyte(s)": [
        "Lupus Anticoagulant"
    ],
    "Specimen Type(s)": [
        "Human citrated platelet-poor plasma"
    ],
    "Specimen Container(s)": [
        "Vial"
    ],
    "Instrument(s)/Platform(s)": [
        "IL Coagulation systems",
        "ACL TOP Family",
        "ACL ELITE",
        "ACL ELITE PRO",
        "ACL 8",
        "ACL 9",
        "ACL 10000",
        "ACL Futura",
        "ACL Advance",
        "ACL Classic (100-7000)"
    ],
    "Method(s)/Technology(ies)": [
        "Lyophilized control material"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for HemosIL LA Positive and Negative Controls as quality control materials for Lupus Anticoagulant assays on IL Coagulation systems",
    "Indications for Use Summary": "Intended for use as positive and negative quality controls in Lupus Anticoagulant assays on specified IL Coagulation systems",
    "fda_folder": "Hematology"
}